 SAN DIEGO, Jan. 18, 2023 GLOBE NEWSWIRE Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Y-mAbs Therapeutics, Inc. NASDAQ: YMAB. The class action is on behalf of shareholders who purchased Y-mAbs Therapeutics between October 6, 2020 and October 28, 2022, both dates ... The post Y-maBs Therapeutics Class Action Lawsuit Announced: Johnson Fistel Encourages Shareholders to Submit Their Information appeared first on F... 